GCG and obesity due to melanocortin 4 receptor deficiency: The recent demonstration of the effectiveness of tirzepatide [118] and retatrutide [119] holds promise for combination therapy targeting GLP-1, GIP, and glucagon to promote weight loss and reduce obesity-related co-morbidities.